Mitsuaki Nishikimi1,2, Takayuki Ogura3, Kazuki Nishida4, Kei Hayashida1, Ryo Emoto4, Shigeyuki Matsui4, Naoyuki Matsuda2, Taku Iwami5. 1. Laboratory of Critical Care Physiology at the Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY. 2. Department of Emergency and Critical Care Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan. 3. Department of Emergency Medicine and Critical Care Medicine, SAISEIKAI Utsunomiya Hospital, Utsunomiya, Japan. 4. Department of Biostatistics, Nagoya University Graduate School of Medicine, Nagoya, Japan. 5. Department of Preventive Services, School of Public Health, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Abstract
OBJECTIVES: The optimal target temperature during targeted temperature management for patients after cardiac arrest remains under debate. The aim of this study was to evaluate the association between targeted temperature management at lower target temperatures and the neurologic outcomes among patients classified by the severity of postcardiac arrest syndrome. DESIGN: A multicenter observational study from the out-of-hospital cardiac arrest registry of the Japanese Association for Acute Medicine, which is a nationwide prospective registry of out-of-hospital cardiac arrest patients. SETTING: A total of 125 critical care medical centers or hospitals with an emergency care department across Japan. PATIENTS: A total of 1,111 out-of-hospital cardiac arrest patients who had received targeted temperature management. MEASUREMENTS AND MAIN RESULTS: We divided all 1,111 postcardiac arrest syndrome patients treated with targeted temperature management into two groups: those who received targeted temperature management at a lower target temperature (33-34°C) and those who received targeted temperature management at a higher target temperature (35-36°C). In regard to classification of the patients, we divided the patients into three categories of severity (low, moderate, and high severities) using the risk classification tool, post-Cardiac Arrest Syndrome for Therapeutic hypothermia, which was previously validated. The primary outcome was the percentage of patients with a good neurologic outcome at 30 days, and the secondary outcome was the survival rate at 30 days. Multivariate analysis showed that targeted temperature management at 33-34°C was significantly associated with a good neurologic outcome and survival at 30 days in the moderate severity (odds ratio, 1.70 [95% CI, 1.03-2.83] and 1.90 [95% CI, 1.15-3.16], respectively), but not in the patients of low or high severity (pinteraction = 0.033). Propensity score analysis also showed that targeted temperature management at 33-34°C was associated with a good neurologic outcome in the moderate-severity group (p = 0.022). CONCLUSIONS: Targeted temperature management at 33-34°C was associated with a significantly higher rate of a good neurologic outcome in the moderate-severity postcardiac arrest syndrome group, but not in the low- or high-severity group.
OBJECTIVES: The optimal target temperature during targeted temperature management for patients after cardiac arrest remains under debate. The aim of this study was to evaluate the association between targeted temperature management at lower target temperatures and the neurologic outcomes among patients classified by the severity of postcardiac arrest syndrome. DESIGN: A multicenter observational study from the out-of-hospital cardiac arrest registry of the Japanese Association for Acute Medicine, which is a nationwide prospective registry of out-of-hospital cardiac arrestpatients. SETTING: A total of 125 critical care medical centers or hospitals with an emergency care department across Japan. PATIENTS: A total of 1,111 out-of-hospital cardiac arrestpatients who had received targeted temperature management. MEASUREMENTS AND MAIN RESULTS: We divided all 1,111 postcardiac arrest syndromepatients treated with targeted temperature management into two groups: those who received targeted temperature management at a lower target temperature (33-34°C) and those who received targeted temperature management at a higher target temperature (35-36°C). In regard to classification of the patients, we divided the patients into three categories of severity (low, moderate, and high severities) using the risk classification tool, post-Cardiac Arrest Syndrome for Therapeutic hypothermia, which was previously validated. The primary outcome was the percentage of patients with a good neurologic outcome at 30 days, and the secondary outcome was the survival rate at 30 days. Multivariate analysis showed that targeted temperature management at 33-34°C was significantly associated with a good neurologic outcome and survival at 30 days in the moderate severity (odds ratio, 1.70 [95% CI, 1.03-2.83] and 1.90 [95% CI, 1.15-3.16], respectively), but not in the patients of low or high severity (pinteraction = 0.033). Propensity score analysis also showed that targeted temperature management at 33-34°C was associated with a good neurologic outcome in the moderate-severity group (p = 0.022). CONCLUSIONS: Targeted temperature management at 33-34°C was associated with a significantly higher rate of a good neurologic outcome in the moderate-severity postcardiac arrest syndrome group, but not in the low- or high-severity group.
Authors: Hyo Joon Kim; Chun Song Youn; Kyu Nam Park; Young-Min Kim; Byung Kook Lee; Kyung Woon Jeung; Won Young Kim; Seung Pill Choi; Soo Hyun Kim Journal: PLoS One Date: 2022-07-22 Impact factor: 3.752
Authors: Joachim Düring; Martin Annborn; Alain Cariou; Michelle S Chew; Josef Dankiewicz; Hans Friberg; Matthias Haenggi; Zana Haxhija; Janus C Jakobsen; Halvor Langeland; Fabio Silvio Taccone; Matthew Thomas; Susann Ullén; Matt P Wise; Niklas Nielsen Journal: Crit Care Date: 2022-07-31 Impact factor: 19.334
Authors: Betty Y Yang; Natalie Bulger; Richard Chocron; Catherine R Counts; Chris Drucker; Lihua Yin; Megin Parayil; Nicholas J Johnson; Nona Sotoodehenia; Peter J Kudenchuk; Michael R Sayre; Thomas D Rea Journal: JAMA Netw Open Date: 2022-08-01